Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jennifer Gallardo-Cóndor has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An updated checklist of mosquitoes (Diptera, Culicidae) of Ecuador: new records and public health significance

    by Patricio Ponce, Varsovia Cevallos, Andrés Carrazco-Montalvo, Jennifer Gallardo-Cóndor, Valentina Arévalo, Ximena Galarza, Josefina Coloma

    Mosquitoes are major vectors of human and animal diseases, making their accurate identification essential for vector surveillance and control. However, morphological identification has often been challenging, requiring taxonomic expertise and well-preserved specimens. Molecular markers, particularly DNA barcoding, offer an effective alternative for identifying both adult and immature stages. Ecuador is one of the most biodiverse countries in the world, a diversity that is also evident in its Culicidae fauna. This study provides a comprehensive revision of Ecuadorian mosquitoes, updating the national checklist and emphasizing species of public health importance. For species identification, an integrative approach was used combining morphology and DNA barcoding (COI and ITS2 regions). We list 266 species in 22 genera, of which 17 species are new national records, and 33 species are validated through molecular analysis. The updated checklist highlights Ecuador’s Culicidae diversity across its biogeographic regions, which represent 7% of the world’s mosquito diversity. These findings provide a critical foundation for future entomological research and vector control in the country.

  • Open Access

    Advanced Pathogen Monitoring in Penaeus vannamei from Three Latin American Regions: Passive Surveillance Part 2

    by Pablo Intriago, Bolivar Montiel, Mauricio Valarezo, Jennifer Gallardo, Yamilis Cataño

    This study presents the second phase of a year-long investigation comparing multiple PCR analyses and histological examinations to confirm the presence of characteristic lesions of each pathogen in three different regions of Latin America. More than 20 agents, including DNA and RNA viruses, bacteria and microsporidia, have been targeted. In addition to wild Penaeus vannamei, which was studied previously, samples of wild P. stylirostris and P. monodon were included. Notably, a positive PCR test result alone does not confirm the presence of a viable pathogen or a disease state. Similarly, positive PCR results do not necessarily correlate with the presence of histological lesions characteristic of the targeted pathogen. Wenzhou shrimp virus 8 (WzSV8) was found to be widespread among shrimp in all regions, including both farm-raised and wild populations. Histopathological analysis indicated that shrimp typically presented coinfections, such as WzSV8, Decapod hepanhamaparvovirus (DHPV), chronic midgut inflammation, and tubule distension/epithelial atrophy, consistent with the toxicity of Pir A/B or another bacterial toxin. Bacterial muscle necrosis was also found in some regions. In general, bacterial infection was the dominant pathology in all three regions during the year. We also postulate that both WzSV8 and DHPV can infect not only hepatopancreatic cells but also cells in the ceca and intestine.


  • Open Access

    Advanced Pathogen Monitoring in Penaeus vannamei from Three Latin American Regions: Passive Surveillance Part 2

    by Pablo Intriago, Bolivar Montiel, Mauricio Valarezo, Jennifer Gallardo, Yamilis Cataño

    This study presents the second phase of a year-long investigation comparing multiple PCR anal-yses and histological examinations to confirm the presence of characteristic lesions for each path-ogen in three different regions of Latin America. More than 20 agents, including DNA and RNA viruses, bacteria and microsporidia, have been targeted. In addition to wild P. vannamei, which was studied previously, samples of wild P. stylirostris and P. monodon were included. Notably, a positive PCR test result alone does not confirm the presence of a viable pathogen or a disease state. Similarly, positive PCR results do not necessarily correlate with the presence of histological le-sions characteristic of the targeted pathogen. Wenzhou shrimp virus 8 (WzSV8) was found to be widespread among shrimp in all regions, including both farm-raised and wild populations. Histo-pathological analysis indicated that shrimp typically presented coinfections, such as WzSV8, dec-apod hepanhamaparvovirus (DHPV), chronic midgut inflammation, and tubule disten-sion/epithelial atrophy, consistent with the toxicity of Pir A/B or another bacterial toxin. Bacterial muscle necrosis was also found in some regions. In general, bacterial infection was the dominant pathology in all three regions during the year. We also postulate that both WzSV8 and DHPV can infect not only hepatopancreatic cells but also cells in the ceca and intestine.


  • Open Access

    Las Bolitas Syndrome in Penaeus vannamei Hatcheries in Latin America

    by Pablo Intriago, Bolivar Montiel, Mauricio Valarezo, Xavier Romero, Kelly Arteaga, Nicole Cercado, Milena Burgos, Andrew P. Shinn, Alejandra Montenegro, Andrés Medina, et al.

    In September 2023, several hatcheries in Latin America experienced significant mortality rates, up to 90%, in zoea stage 2 of Penaeus vannamei. Observations of fresh mounts revealed structures resembling lipid droplets, similar to those seen in a condition known as “las bolitas syndrome”. Routine histopathological examinations identified detached cells and tissues in the digestive tracts of affected zoea, contrasting with the typical algal cell contents seen in healthy zoea. Polymerase chain reaction (PCR) testing for over 20 known shrimp pathogens indicated minimal differences between diseased and healthy batches. Both groups tested negative for acute hepatopancreatic necrosis disease (AHPND) but positive for Vibrio species and Rickettsia-like bacteria in the diseased samples. Histological analyses of the affected zoea revealed characteristic tissue degeneration in the hepatopancreas, forming spheres that eventually migrated into the upper gut, midgut, and midgut caeca, a pathology identified as bolitas syndrome (BS). Microbiological assessments revealed Vibrio species at concentrations of 106 CFU zoea/g in affected zoea, approximately two orders of magnitude higher than in healthy zoea. Bacterial isolation from both healthy and BS-affected zoea on thiosulphate–citrate–bile salts–sucrose (TCBS) agar and CHROMagar™ (Paris, France), followed by identification using API 20E, identified six strains of Vibrio alginolyticus. Despite similarities to “las bolitas syndrome” in fresh mounts, distinct histopathological differences were noted, particularly the presence of sloughed cells in the intestines and variations in hepatopancreatic lobes. This study highlights the critical need for further research to fully understand the etiology and pathology of bolitas syndrome in zoea stage 2 of P. vannamei to develop effective mitigation strategies for hatchery operations.


  • Open Access

    Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine

    by Jennifer Gallardo-Cóndor, Pablo Naranjo, Sebastián Atarihuana, Dayana Coello, Patricia Guevara-Ramírez, Rodrigo Flores-Espinoza, Germán Burgos, Andrés López-Cortés, Alejandro Cabrera-Andrade

    Purpose: Thiopurine S-methyltransferase (TPMT) is an enzyme that metabolizes purine analogs, agents used in the treatment of acute lymphoblastic leukemia. Improper drug metabolism leads to toxicity in chemotherapy patients and reduces treatment effectiveness. TPMT variants associated with reduced enzymatic activity vary across populations. Therefore, studying these variants in heterogeneous populations, such as Ecuadorians, can help identify molecular causes of deficiency for this enzyme. Methods: We sequenced the entire TPMT coding region in 550 Ecuadorian individuals from Afro-Ecuadorian, Indigenous, Mestizo, and Montubio ethnicities. Moreover, we conducted an ancestry analysis using 46 informative ancestry markers. Results: We identified 8 single nucleotide variants in the coding region of TPMT. The most prevalent alleles were TPMT*3A, TPMT*3B, and TPMT*3C, with frequencies of 0.055, 0.012, and 0.015, respectively. Additionally, we found rare alleles TPMT*4 and TPMT*8 with frequencies of 0.005 and 0.003. Correlating the ancestry proportions with TPMT-deficient genotypes, we observed that the Native American ancestry proportion influenced the distribution of the TPMT*1/TPMT*3A genotype (OR = 5.977, p = 0.002), while the contribution of African ancestral populations was associated with the TPMT*1/TPMT*3C genotype (OR = 9.769, p = 0.003). The rates of TPMT-deficient genotypes observed in Mestizo (f = 0.121) and Indigenous (f = 0.273) groups provide evidence for the influence of Native American ancestry and the prevalence of the TPMT*3A allele. In contrast, although Afro-Ecuadorian groups demonstrate similar deficiency rates (f = 0.160), the genetic factors involved are associated with contributions from African ancestral populations, specifically the prevalent TPMT*3C allele. Conclusion: The distribution of TPMT-deficient variants offers valuable insights into the populations under study, underscoring the necessity for genetic screening strategies to prevent thiopurine toxicity events among Latin American minority groups.


  • Open Access

    Genetic Variations of the DPYD Gene and Its Relationship with Ancestry Proportions in Different Ecuadorian Trihybrid Populations

    by Camila Farinango, Jennifer Gallardo-Cóndor, Byron Freire-Paspuel, Rodrigo Flores-Espinoza, Gabriela Jaramillo-Koupermann, Andrés López-Cortés, Germán Burgos, Eduardo Tejera, Alejandro Cabrera-Andrade

    Dihydropyrimidine dehydrogenase is one of the main pharmacological metabolizers of fluoropyrimidines, a group of drugs widely used in clinical oncology. Around 20 to 30% of patients treated with fluoropyrimidines experience severe toxicity caused by a partial or total decrease in enzymatic activity. This decrease is due to molecular variants in the DPYD gene. Their prevalence and allelic frequencies vary considerably worldwide, so their description in heterogeneous groups such as the Ecuadorian population will allow for the description of pharmacogenetic variants and proper characterization of this population. Thus, we genotyped all the molecular variants with a predictive value for DPYD in a total of 410 Ecuadorian individuals belonging to Mestizo, Afro-Ecuadorian, and Indigenous ethnic groups. Moreover, we developed a genetic ancestry analysis using 46 autosomal ancestry informative markers. We determined 20 genetic variations in 5 amplified regions, including 3 novel single nucleotide variants. The allele frequencies for DPYD variants c.1627G>A (*5, rs1801159), c.1129-15T>C (rs56293913), c.1218G>A (rs61622928), rs1337752, rs141050810, rs2786783, rs2811178, and g.97450142G>A (chr1, GRCh38.p13) are significantly related to Native American and African ancestry proportions. In addition, the FST calculated from these variants demonstrates the closeness between Indigenous and Mestizo populations, and evidences genetic divergence between Afro-Ecuadorian groups when compared with Mestizo and Indigenous ethnic groups. In conclusion, the genetic variability in the DPYD gene is related to the genetic component of ancestral populations in different Ecuadorian ethnic groups. The absence and low frequency of variants with predictive value for fluoropyrimidine toxicity such as DPYD *2A, HapB3, and c.2846A>T (prevalent in populations with European ancestry) is consistent with the genetic background found.